Protocol 20050222: Sub-Investigator, A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbopoetin aIfa Treatment on Mortality and Morbidity in Heart Failure with Symptomatic Left Ventricular Systolic D

Date: August 06, 2012|Source: No Source